Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01751620
Other study ID # ATN 108
Secondary ID
Status Completed
Phase N/A
First received December 14, 2012
Last updated February 27, 2017
Start date January 2013
Est. completion date June 2015

Study information

Verified date October 2016
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study is a two-group randomized repeated measures design that will examine the efficacy of Project ACCEPT (Adolescents Coping, Connecting, Empowering and Protecting Together) to improve engagement in care among youth newly diagnosed with HIV at five AMTU sites across the United States. Youth will be randomized into one of two study arms; Project ACCEPT, the intervention, or HEALTH, the health education attention-controlled comparison condition. Both arms consist of two individual sessions followed by six group sessions and a final individual session which is expected to take approximately nine weeks after which youth will have four follow-up visits at the following time points:

- post intervention (immediately after the last session);

- 3 months post the last session;

- 6 months post the last session; and

- 12 months post the last session. The trial will be repeated in up to three waves.


Recruitment information / eligibility

Status Completed
Enrollment 167
Est. completion date June 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender All
Age group 16 Years to 24 Years
Eligibility Inclusion Criteria:

- HIV-infected and aware of his/her status as documented by medical record review or verbal verification by provider (i.e., medical or mental health care provider, case manager, social worker, etc.);

- Received HIV diagnosis within the past 12 months (+ 3 months) at the time of consent/assent as documented by medical record review or verbal verification with referring professional (i.e., medical or mental health care provider, case manager, social worker, etc.);

- Between the ages of 16-24 (inclusive) at the time of informed consent/assent;

- Receives services at one of the selected AMTUs or one of their community partners;

- Willing to participate in both the individual and group sessions;

- Ability to speak and understand spoken English;

- Able to understand and willing to provide signed informed consent/assent in English or Spanish; and

- Willingness to provide signed informed consent or assent with parental/legal guardian permission as applicable.

Exclusion Criteria:

- Participated in a previous wave, if enrolling into Wave 2 or 3;

- Intoxicated or under the influence of alcohol or other substances at the time of consent/assent;

- Visibly distraught and/or visibly emotionally unstable (i.e., exhibiting suicidal, homicidal, or violent behavior) in the opinion of the site personnel would interfere with the ability to give true informed consent; and

- Any concurrent participation in other behavioral studies. Permission from the protocol team may be provided for uncertain cases.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Project ACCEPT
The intervention, Project ACCEPT, combines weekly individual and group sessions that address a range of issues that impact engagement in care for youth living with HIV, including stigma, disclosure, health relationships, substance use, and future life plans.
HEALTH
The comparison condition, HEALTH, matches Project ACCEPT in number of sessions and duration. The weekly sessions will cover information on alcohol, drugs, HIV and other sexually transmitted diseases (STDs) to meet the ethical responsibility to provide risk reduction information to youth assigned.

Locations

Country Name City State
United States Stroger Hospital and the CORE Center Chicago Illinois
United States Wayne State University Detroit Michigan
United States St. Jude Childrens Research Hospital Memphis Tennessee
United States University of Miami School of Medicine Miami Florida

Sponsors (3)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention Conduct a randomized controlled trial to examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention (HEALTH). The goals of the intervention are to improve engagement in care, decrease psychosocial barriers to care, and decrease sexual risk for youth newly diagnosed with HIV. 3 years
Secondary Explore the relationship between HIV biomarkers and participant's level of engagement in care Explore the relationship between HIV biomarkers (i.e., CD4 and viral load) and participant's level of engagement in care. 3 years

External Links